MicroRNA signatures highlight new breast cancer subtypes

被引:33
作者
Bhattacharyya, Malay [1 ]
Nath, Joyshree [2 ]
Bandyopadhyay, Sanghamitra [2 ]
机构
[1] Indian Inst Engn Sci & Technol, Dept Informat Technol, Sibpur 711103, Howrah, India
[2] Indian Stat Inst, Machine Intelligence Unit, Kolkata 700108, India
关键词
Breast cancer; MicroRNA; Cancer subtype; Survival analysis; EXPRESSION; TUMORS; RISK;
D O I
10.1016/j.gene.2014.11.053
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
MicroRNAs (miRNAs) are a kind of short non-coding RNAs, of about 22 nucleotides in length, which modulate and sometimes degrade the target mRNAs thereby regulating a number of cellular functions. Recent research in this area establishes the involvement of miRNAs in various disease progressions, including certain types of cancer development Further, genome-wide expression profiling of miRNAs has been proven to be useful for differentiating various cancer types. In this paper, we have used miRNA expression profiles over a large set of breast cancer tumor samples for identifying subtypes of breast cancers. The experimental results demonstrate that miRNAs carry a unique signature that distinguishes cancer subtypes and reveal new cancer subtypes. Additional survival analyses based on clinical data also strengthen this claim. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:192 / 198
页数:7
相关论文
共 50 条
  • [31] The Association Between Mammographic Density and Molecular Subtypes of Breast Cancer
    Kilic, Murat Ozgur
    Ucar, Ali Yalcin
    [J]. INDIAN JOURNAL OF SURGERY, 2020, 82 (02) : 191 - 196
  • [32] Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma
    Horst, K. C.
    Hancock, S. L.
    Ognibene, G.
    Chen, C.
    Advani, R. H.
    Rosenberg, S. A.
    Donaldson, S. S.
    Hoppe, R. T.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (04) : 848 - 851
  • [33] Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status
    Melissa Rotunno
    Xuezheng Sun
    Jonine Figueroa
    Mark E Sherman
    Montserrat Garcia-Closas
    Paul Meltzer
    Tyisha Williams
    Sallie Smith Schneider
    D Joseph Jerry
    Xiaohong R Yang
    Melissa A Troester
    [J]. Breast Cancer Research, 16
  • [34] Intrinsic subtypes and genomic signatures of primary breast cancer and prognosis after systemic relapse
    Falato, Claudette
    Tobin, Nicholas P.
    Lorent, Julie
    Lindstrom, Linda S.
    Bergh, Jonas
    Foukakis, Theodoros
    [J]. MOLECULAR ONCOLOGY, 2016, 10 (04) : 517 - 525
  • [35] Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer
    Adhami, Masoumeh
    MotieGhader, Habib
    Haghdoost, Ali Akbar
    Afshar, Reza Malekpour
    Sadeghi, Balal
    [J]. GENOMICS, 2020, 112 (01) : 135 - 143
  • [36] PROGNOSTIC SIGNATURES OF BREAST CANCER: PEROU'S MOLECULAR SUBTYPES AND SCHMIDT'S METAGENES
    Cadenas, Cristina
    [J]. EXCLI JOURNAL, 2012, 11 : 204 - 207
  • [37] Genomic Signatures in Luminal Breast Cancer
    Puppe, Julian
    Seifert, Tabea
    Eichler, Christian
    Pilch, Henryk
    Mallmann, Peter
    Malter, Wolfram
    [J]. BREAST CARE, 2020, 15 (04) : 355 - 365
  • [38] Cecal microbiota and mammary gland microRNA signatures are related and modifiable by dietary flaxseed with implications for breast cancer risk
    Wu, Diana
    Thompson, Lilian U.
    Comelli, Elena M.
    [J]. MICROBIOLOGY SPECTRUM, 2024, 12 (01):
  • [39] Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancersin vitro
    Hirschfeld, Marc
    Ge, Isabel
    Rucker, Gerta
    Waldschmidt, Julia
    Mayer, Sebastian
    Jager, Markus
    Voigt, Matthias
    Kammerer, Bernd
    Nothling, Claudia
    Berner, Kai
    Weiss, Daniela
    Asberger, Jasmin
    Erbes, Thalia
    [J]. MOLECULAR MEDICINE REPORTS, 2020, 22 (05) : 4048 - 4060
  • [40] MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer
    Ozgun, Alpaslan
    Karagoz, Bulent
    Bilgi, Oguz
    Tuncel, Tolga
    Baloglu, Huseyin
    Kandemir, Emin G.
    [J]. ONKOLOGIE, 2013, 36 (03): : 115 - 118